Navigation Links
Cryo-Cell Announces Strategic Partnership With S-Evans Biosciences, Inc.
Date:8/11/2009

HANGZHOU, China, Aug. 11 /PRNewswire-FirstCall/ -- Cryo-Cell International, Inc. (OTC Bulletin Board: CCEL), one of the largest and most established leaders in stem cell innovation today announced that it has signed an exclusive license agreement with S-Evans Biosciences, Inc. (SEB), a privately-held stem cell and genomics technology company located near Shanghai in Hangzhou, Zhejiang Province, People's Republic of China. The partnership will allow S-Evans Biosciences to market and manufacture proprietary C'elle(SM) menstrual stem cell technology including the processing and storage of menstrual stem cells (MenSCs) exclusively throughout mainland China. It will also allow SEB to conduct scientific research studies using Cryo-Cell's proprietary C'elle(SM) menstrual stem technology to identify future potential therapeutic applications for a broad possible range of diseases that may affect millions of people. The exclusive license agreement with SEB will provide Cryo-Cell with future royalty fees from the processing and annual storage of menstrual stem cells.

SEB is a privately-held company that collaborates with several institutions including Zhejiang University; local hospitals; and Zhejiang-California International Nanosystems Institute (ZCNI), a Sino-US co-founded institute for biomedicine and nanotechnology research located on Zhejiang University campus. In addition to SEB's business plans to market and manufacture C'elle menstrua
'/>"/>

SOURCE Cryo-Cell International, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related biology technology :

1. Cryo-Cell International, Inc. Reports First Quarter 2009 Results
2. Cryo-Cell Renews Upromise Industry-Exclusive Agreement
3. Cryo-Cell International, Inc. Reports Third Quarter 2008 Results
4. Cryo-Cell International and EndGenitor Technologies Announce Research Collaboration
5. Cryo-Cell International, Inc. Reports Second Quarter 2008 Results
6. Cryo-Cell International, Inc. Reports First Quarter 2008 Results
7. Cryo-Cell International, Inc. Reports Results for Fiscal 2007
8. Cryo-Cell Announces Research Collaboration Agreement with Saneron CCEL Therapeutics, Inc.
9. WuXi PharmaTech Announces Second-Quarter 2009 Results
10. ValGenesis, Inc. Announces Integration of ValGenesis Solution with Microsoft SharePoint Server
11. China Sky One Medical, Inc. Announces Conference Call to Discuss Second Quarter 2009 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... York , May 21, 2013 ... Transparency Market Research ( http://www.transparencymarketresearch.com ) "Biochip Products and ... IVD Tests) - U.S. Industry Analysis, Size, Share, Growth, Trends and ... billion in 2011 and is expected to grow at ... reach an estimated value of USD 4.7 billion in ...
(Date:5/21/2013)... -- Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of biologics ... announced today that Jeffrey Riley , CEO, ... MicroCap Conference on Thursday, May 30, 2013 in ... Mr. Riley is scheduled to present at 10:00 a.m. (Eastern ... can be accessed by logging onto the web at ...
(Date:5/21/2013)... 21, 2013 Inflamax scientists worked ... ITN to design the study, which will provide ... clinical models used in the study of allergy ... Allergen Challenge (NAC) models. Although both the models ... to date no direct comparison between the allergic ...
(Date:5/21/2013)... 21, 2013 The Formulate Fusion Fabric ... for sales and marketing teams looking for a fully-functional package ... kit as “everything you’ll need to put together a stunning ... comes with a number of displays and accessories that can ... feet by 20 feet in size. These components vary from ...
Breaking Biology Technology:The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 2The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 3The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 4The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research 5Synthetic Biologics to Present at the 2nd Annual Marcum LLP MicroCap Conference 2Inflamax Research selected by the Immune Tolerance Network and the National Institutes of Health to conduct a landmark clinical study on the underlying mechanisms of allergic inflammation. 2GLM Displays Announces All-in-One Formulate Fusion Fabric Display Kit 2
... 26 Biomerix Corporation announced today that it has ... to market REVIVE(TM). Constructed using the Biomerix Biomaterial(TM), REVIVE ... and can be utilized in a variety of soft ... With more than 700,000 procedures per year, inguinal hernia ...
... Germany, February 26 ,EUCODIS Bioscience, a company developing ... (LAH), a company developing and marketing products,for animal ... of a,major development milestone in their collaboration agreement ... EUCODIS Bioscience has completed ...
... ScreenCancer AS, a Norwegian,company offering cancer screening ... today announced that it has added the ... its European Cancer,Screening Program. The company,s two-year ... Quest Diagnostics Incorporated (NYSE: DGX ...
Cached Biology Technology:Biomerix Corporation Announces FDA Clearance and Market Launch of REVIVE(TM) for Use in Soft Tissue Repair Procedures 2EUCODIS Bioscience and Lohmann Animal Health Announce Achievement of Major Development Milestone 2EUCODIS Bioscience and Lohmann Animal Health Announce Achievement of Major Development Milestone 3ScreenCancer Adds InSure(R) FIT(TM) Colorectal Cancer Screening Test to European Cancer Screening Program 2ScreenCancer Adds InSure(R) FIT(TM) Colorectal Cancer Screening Test to European Cancer Screening Program 3
(Date:5/21/2013)... is an uphill battle? Try staying fit in space, ... muscle and bone. , That,s the challenge a group ... new three-year, $1.2 million grant from NASA. Their goal ... exploratory missions. , "You could give astronauts the best ... them to stick to it, it isn,t going to ...
(Date:5/21/2013)... CAMBRIDGE, MA -- Over the past few decades, scientists ... including angioplasty balloons and metallic stents. While generally effective, ... of side effects. , A new study from MIT ... combines the benefits of angioplasty balloons and drug-releasing stents, ... a balloon is inflated in the artery for only ...
(Date:5/21/2013)... path of insulin action in cells in precise detail ... understanding what goes wrong in diabetes. , The ... James from Sydney,s Garvan Institute of Medical Research, is ... prestigious journal Cell Metabolism . , First discovered ... role in the body because it helps us lower ...
Breaking Biology News(10 mins):Fueling fitness on the final frontier 2Evaluating a new way to open clogged arteries 2Evaluating a new way to open clogged arteries 3Insight into the dazzling impact of insulin in cells 2Insight into the dazzling impact of insulin in cells 3
... the days shortening toward winter, many people will begin to ... devastating. About 6 percent of the U.S. population ... that begins in the fall and continues through winter. Sufferers ... in the morning. The disorder, which is not well ...
... 3, 2008 Move over, oil, gasoline, and coal. ... to help supply an energy-hungry world in the 21st ... American Chemical Society,s Global Challenges/Chemistry Solutions series. Those fuels ... and other sources that can help power an energy-hungry ...
... professor Karen Warkentin, working at the Smithsonian Tropical ... frog embryos at a very early developmental stage ... reported in the Nov. 7, 2008 issue of ... initial responses to the environment may be critical ...
Cached Biology News:Seasonal affective disorder may be linked to genetic mutation, study suggests 2Fuels of the future may come from 'ice that burns,' water and sunshine 2Red-eyed treefrog embryos actively avoid asphyxiation inside their eggs 2
Mouse monoclonal antibody to ST8SIA2 - ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2...
Mouse monoclonal antibody raised against a partial recombinant COG2. NCBI Entrez Gene ID = COG2...
Mouse monoclonal antibody raised against a partial recombinant RAB11B. NCBI Entrez Gene ID = RAB11B...
...
Biology Products: